HighTower Advisors, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$14,000
-62.2%
21,588
-40.2%
0.00%
Q3 2022$37,000
+164.3%
36,074
+67.1%
0.00%
Q2 2022$14,000
-33.3%
21,585
-12.2%
0.00%
Q1 2022$21,000
-53.3%
24,585
-11.7%
0.00%
Q4 2021$45,000
-32.8%
27,8380.0%0.00%
Q3 2021$67,000
+3.1%
27,838
+13.2%
0.00%
Q2 2021$65,000
-47.2%
24,585
-0.3%
0.00%
Q1 2021$123,000
+241.7%
24,660
+9.2%
0.00%
Q4 2020$36,000
+100.0%
22,585
+15.3%
0.00%
Q3 2020$18,000
-10.0%
19,585
+0.0%
0.00%
Q2 2020$20,00019,5840.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 508,000$249,0000.10%
1492 Capital Management LLC 150,000$74,0000.09%
Uniplan Investment Counsel, Inc. 2,069,121$1,014,0000.08%
ARDSLEY ADVISORY PARTNERS LP 70,000$34,0000.01%
Spark Investment Management LLC 35,210$17,0000.01%
TOCQUEVILLE ASSET MANAGEMENT L.P. 191,000$94,0000.00%
WealthPLAN Partners, LLC 20,000$15,0000.00%
Procyon Advisors, LLC 2,500$1,0000.00%
Renaissance Technologies 1,078,379$529,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders